Phase 1 Study of LQT-1213 in Healthy Adults
NCT05759962
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Long QT Syndrome
Interventions
DRUG:
LQT-1213
OTHER:
Placebo
Sponsor
Thryv Therapeutics, Inc.